NASDAQ:PLRZ Polyrizon (PLRZ) Stock Price, News & Analysis $10.99 -0.04 (-0.36%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$10.66 -0.33 (-2.97%) As of 09/18/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsNews and TrendsOwnershipSEC Filings About Polyrizon Stock (NASDAQ:PLRZ) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Polyrizon alerts:Sign Up Key Stats Today's Range$10.36▼$11.0750-Day Range$9.72▼$15.3152-Week Range$2.88▼$18.20Volume31,963 shsAverage Volume80,063 shsMarket Capitalization$23.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Polyrizon Ltd. is an Israel-based biotechnology company developing hydrogel-based nasal products intended to provide localized protection in the nasal cavity. Its technology is designed to create a physical barrier that may help reduce exposure to airborne pathogens, allergens and other harmful particles before they enter the respiratory system. The company’s platform focuses on nasal formulations and delivery systems that can adhere to the nasal mucosa and support applications in respiratory health. Potential product areas include protection against respiratory viruses, allergy-related symptoms and environmental pollutants, although the company’s products remain subject to development, testing and applicable regulatory requirements. Polyrizon’s research and development activities are centered in Israel, with its products intended for potential use in international markets. The company’s technology is being developed for healthcare and consumer applications, but the availability, commercialization and regulatory status of specific products may vary by jurisdiction.AI Generated. May Contain Errors. Read More Polyrizon Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks13th Percentile Overall ScorePLRZ MarketRank™: Polyrizon scored higher than 13% of companies evaluated by MarketBeat, and ranked 841st out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPolyrizon has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePolyrizon has only been the subject of 1 research reports in the past 90 days.Read more about Polyrizon's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioPolyrizon has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.20% of the float of Polyrizon has been sold short.Short Interest Ratio / Days to CoverPolyrizon has a short interest ratio ("days to cover") of 0.92, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Polyrizon has recently decreased by 27.24%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPolyrizon does not currently pay a dividend.Dividend GrowthPolyrizon does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 3 people have searched for PLRZ on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Polyrizon insiders have not sold or bought any company stock.Percentage Held by InstitutionsPolyrizon has minimal institutional ownership at this time.Read more about Polyrizon's insider trading history. Receive PLRZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Polyrizon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PLRZ Stock News HeadlinesPolyrizon (NASDAQ:PLRZ) Downgraded to "Sell" Rating by Wall Street ZenSeptember 12, 2026 | americanbankingnews.comPolyrizon Raises $4 Million in Registered Direct Offering and Private PlacementSeptember 4, 2026 | tipranks.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.September 20 at 1:00 AM | Profits Run (Ad)Polyrizon Ltd. Closes $4 Million Registered Direct Offering and Concurrent Private PlacementSeptember 4, 2026 | quiverquant.comQPolyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private PlacementSeptember 4, 2026 | globenewswire.comPolyrizon Raises $4 Million in Registered Direct Offering and Private PlacementSeptember 4, 2026 | tipranks.comPolyrizon Announces $4 Mln Registered Direct Offering And Private PlacementSeptember 3, 2026 | rttnews.comPolyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private PlacementSeptember 3, 2026 | globenewswire.comSee More Headlines PLRZ Stock Analysis - Frequently Asked Questions How have PLRZ shares performed this year? Polyrizon's stock was trading at $8.49 on January 1st, 2026. Since then, PLRZ stock has increased by 29.4% and is now trading at $10.99. When did Polyrizon's stock split? Polyrizon's stock reverse split before market open on Friday, November 28th 2025.A 1-6 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. When did Polyrizon IPO? Polyrizon (PLRZ) raised $4 million in an initial public offering (IPO) on Tuesday, October 29th 2024. The company issued 958,903 shares at a price of $4.38 per share. How do I buy shares of Polyrizon? Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/20/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (9m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 PLRZ's financial health is in the Green zone, according to TradeSmith. PLRZ has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:PLRZ Previous SymbolNASDAQ:PLRZ CIK1893645 Webwww.polyrizon-biotech.com Phone972-55-433-5665FaxN/AEmployees1Year Founded2005Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio29.03 Quick Ratio29.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$13.05 per share Price / Book0.84Miscellaneous Outstanding Shares2,140,000Free FloatN/AMarket Cap$23.52 million OptionableN/A Beta-1.39 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:PLRZ) was last updated on 9/20/2026 by MarketBeat.com Staff. From Our Partners$40,000,000,000,000The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...American Alternative | Sponsored“Elon’s nightmare” could fund your retirementMarc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYou’ve never seen anything like this beforeFor centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...Porter & Company | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredNVDA CEO says it’s a "once-in-a-generation opportunity"NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...Monument Traders Alliance | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Polyrizon Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Polyrizon With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
